直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • News
  • Finnegan Facts
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • Pro Bono
  • Management
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

Commentary

Keys to Protecting Your MedTech AI from Competitors

September 2021

Medical Design & Outsourcing

The rate of artificial intelligence (AI) patent applications filed annually has doubled between 2002 and 2019. In an episode of MassDevice and Medical Design and Outsourcing’s DeviceTalks Tuesdays, Finnegan partner Anthony Del Monaco discusses how to protect AI intellectual property.

Anthony notes, “Why do you need to protect this IP? The primary reason is because if you don’t protect it, you may lose it.” Anthony further suggests that AI companies can protect IP using both patents and trade secrets, emphasizing that “the real takeaway is to make sure you get protection.”

Read “Keys to Protecting Your MedTech AI from Competitors”

Tags

patent application, license agreement

Related Practices

Prosecution and Portfolio Management

Trade Secrets

Patent Drafting and Prosecution

Related Industries

AI, Electronics, and Information Technology

Artificial Intelligence (AI) and Machine Learning (ML)

Related News

Commentary

New Appellate Opinion in Amazon Biometric Data Case May Signal ‘Narrowing’ Scope of BIPA Litigation, Experts Say

May 20, 2026

Press Release

Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination

May 11, 2026

Commentary

ITC Bars Import of Innoscience Chips Made Before Redesign

May 8, 2026

Commentary

How Litigation Funding Disclosure Could Affect ITC Cases

May 7 , 2026

Commentary

Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict

May 5, 2026

Announcement

Finnegan Partner Ningling Wang Becomes President of Licensing Executives Society International

May 4, 2026

Award/Ranking

Finnegan Wins IP Firm of the Year at the 2026 LSPN Awards

May 1, 2026

Press Release

Finnegan Enhances Its German and European IP Practice with Björn Kalbfus

April 30, 2026

Commentary

Supreme Court Takes Up Generic Drug Labeling Fight

April 29, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP